1006 related articles for article (PubMed ID: 24966602)
1. Pathogenesis of liver cirrhosis.
Zhou WC; Zhang QB; Qiao L
World J Gastroenterol; 2014 Jun; 20(23):7312-24. PubMed ID: 24966602
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
Elpek GÖ
World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
5. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
6. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.
Katsarou A; Moustakas II; Pyrina I; Lembessis P; Koutsilieris M; Chatzigeorgiou A
World J Gastroenterol; 2020 May; 26(17):1993-2011. PubMed ID: 32536770
[TBL] [Abstract][Full Text] [Related]
7. Reversal of liver cirrhosis: current evidence and expectations.
Jung YK; Yim HJ
Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
[TBL] [Abstract][Full Text] [Related]
8. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review).
Cheng QN; Yang X; Wu JF; Ai WB; Ni YR
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760176
[TBL] [Abstract][Full Text] [Related]
9. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development.
Ignat SR; Dinescu S; Hermenean A; Costache M
Cells; 2020 Feb; 9(2):. PubMed ID: 32085494
[TBL] [Abstract][Full Text] [Related]
10. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
11. Zinc finger protein A20 protects rats against chronic liver allograft dysfunction.
Yang J; Xu MQ; Yan LN; Chen XB; Liu J
World J Gastroenterol; 2012 Jul; 18(27):3537-50. PubMed ID: 22826618
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk network among multiple inflammatory mediators in liver fibrosis.
Zhangdi HJ; Su SB; Wang F; Liang ZY; Yan YD; Qin SY; Jiang HX
World J Gastroenterol; 2019 Sep; 25(33):4835-4849. PubMed ID: 31543677
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
14. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.
Ma L; Yang X; Wei R; Ye T; Zhou JK; Wen M; Men R; Li P; Dong B; Liu L; Fu X; Xu H; Aqeilan RI; Wei YQ; Yang L; Peng Y
Cell Death Dis; 2018 Jun; 9(7):718. PubMed ID: 29915227
[TBL] [Abstract][Full Text] [Related]
16. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
[No Abstract] [Full Text] [Related]
17. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis.
Su Q; Kumar V; Sud N; Mahato RI
Adv Drug Deliv Rev; 2018 Apr; 129():54-63. PubMed ID: 29391222
[TBL] [Abstract][Full Text] [Related]
18. Management strategies for liver fibrosis.
Altamirano-Barrera A; Barranco-Fragoso B; Méndez-Sánchez N
Ann Hepatol; 2017; 16(1):48-56. PubMed ID: 28051792
[TBL] [Abstract][Full Text] [Related]
19. Delta-like ligand 4/DLL4 regulates the capillarization of liver sinusoidal endothelial cell and liver fibrogenesis.
Chen L; Gu T; Li B; Li F; Ma Z; Zhang Q; Cai X; Lu L
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1663-1675. PubMed ID: 31233801
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA interplay between hepatic stellate cell quiescence and activation.
Ezhilarasan D
Eur J Pharmacol; 2020 Oct; 885():173507. PubMed ID: 32858048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]